Heterogeneously Dense Breasts denials in California external review

In the California DMHC record, independent physician reviewers decided 12 published external-review cases involving heterogeneously dense breastsand overturned the plan’s denial in 100%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
12
2016–2021
Overturned
100%
12 denials reversed

Most-fought treatments for heterogeneously dense breasts

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Digital Breast Tomosynthesis9
100%
Typical time to a decision
13 days
Most land between 12 and 17 days

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for digital breast tomosynthesis (3D mammogram).The main weakness of mammography is the detection of cancer in women with radiographic dense breasts. While nearly all cancers will be apparent in fatty breasts, only half will be visible in extremely dense breasts. This is a result of the masking or camouflaging of non-calcified cancers by surrounding dense tissue. An advantage of tomosynthesis is better delineation and characterization of breast masses. The primary benefit of digital breast tomosynthesis would be expected to be for non-calcified mammographic findings, such as masses, asymmetries, and distortion. In the most basic application, digital breast tomosynthesis would allow visualization of cancers not apparent by conventional mammography, thus improving sensitivity.
Medical Necessity · 2021 · IMR MN21-35455
Nature of Statutory Criteria/Case Summary: An enrollee has requested breast tomosynthesis for her breast examination. Findings: Three physician reviewers found that tomosynthesis is a technique that was developed several years ago as a problem solving adjunct to routine mammography. Applying the same basic concept as computed tomography (CT) scanning, the logic is that by separating the various layers of breast tissue, one can better detect abnormalities. This has been shown to be most useful in the evaluation of the dense breast. In this particular patient, she was noted to have heterogeneously dense breasts. The ability to separate out the overlapping structures enables the possibility of demonstrating an otherwise occult tumor. The medical literature supports the use of breast tomosynthesis over conventional mammogram due to improved cancer detection rate.
Experimental/Investigational · 2016 · IMR EI16-21741

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving heterogeneously dense breasts, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for heterogeneously dense breasts? Use the California record to prepare.

Explain my denial — freeStart my appeal · $9